{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:53:09Z","timestamp":1781833989079,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02107-9","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:35:12Z","timestamp":1777703712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Abnormal adnexal uptake in 68Ga-FAPI PET\/CT: from physiological variants to malignant characterization"],"prefix":"10.1186","volume":"19","author":[{"given":"Qixin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canran","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3505-5314","authenticated-orcid":false,"given":"Xiaoliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"issue":"8","key":"2107_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMra2108956","volume":"387","author":"RC Sisodia","year":"2022","unstructured":"Sisodia RC, Del Carmen MG. Lesions of the Ovary and Fallopian Tube. N Engl J Med. 2022;387(8):727\u201336.","journal-title":"N Engl J Med"},{"issue":"1","key":"2107_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2107_CR3","first-page":"436","volume":"75","author":"P Kordowitzki","year":"2025","unstructured":"Kordowitzki P, Lange B, Elias KM, et al. Transforming treatment paradigms: Focus on personalized medicine for high-grade serous ovarian cancer. CA Cancer J Clin. 2025;75(5):436\u201360.","journal-title":"CA Cancer J Clin"},{"issue":"18","key":"2107_CR4","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1158\/1078-0432.CCR-16-0316","volume":"22","author":"KL Terry","year":"2016","unstructured":"Terry KL, Schock H, Fortner RT, et al. A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort. Clin Cancer Res. 2016;22(18):4664\u201375.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2107_CR5","doi-asserted-by":"publisher","first-page":"e1003295","DOI":"10.1371\/journal.pmed.1003295","volume":"17","author":"G Funston","year":"2020","unstructured":"Funston G, Hamilton W, Abel G, et al. The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study. PLoS Med. 2020;17(10):e1003295.","journal-title":"PLoS Med"},{"issue":"5","key":"2107_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb PM, Jordan SJ. Global epidemiology of epithelial ovarian cancer. Nat Rev Clin Oncol. 2024;21(5):389\u2013400.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2107_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/IGC.0000000000000586","volume":"26","author":"G Soletormos","year":"2016","unstructured":"Soletormos G, Duffy MJ, Othman Abu Hassan S, et al. Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers. Int J Gynecol Cancer. 2016;26(1):43\u201351.","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"2107_CR8","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.62347\/GSRD2580","volume":"14","author":"F Cheng","year":"2024","unstructured":"Cheng F, Ma X, Cheng Z, et al. Predict value of tumor markers combined with interleukins for therapeutic efficacy and prognosis in ovarian cancer patients. Am J Cancer Res. 2024;14(10):4868\u201379.","journal-title":"Am J Cancer Res"},{"issue":"7","key":"2107_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00259-005-1771-6","volume":"32","author":"SK Kim","year":"2005","unstructured":"Kim SK, Kang KW, Roh JW, et al. Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle. Eur J Nucl Med Mol Imaging. 2005;32(7):757\u201363.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"2107_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/RLU.0b013e31819a208f","volume":"34","author":"EI Schwarz","year":"2009","unstructured":"Schwarz EI, Ramach C, Mende KA, et al. Physiologic FDG uptake in the ovary together with an abdominal wall leiomyoma mimicking metastasizing ovarian cancer on PET\/CT imaging. Clin Nucl Med. 2009;34(4):249\u201350.","journal-title":"Clin Nucl Med"},{"issue":"5","key":"2107_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.canep.2012.03.002","volume":"36","author":"A Han","year":"2012","unstructured":"Han A, Xue J, Hu M, et al. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary. Cancer Epidemiol. 2012;36(5):470\u20135.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"2107_CR12","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1186\/s12885-021-08815-3","volume":"21","author":"X Hu","year":"2021","unstructured":"Hu X, Li D, Liang Z, et al. Indirect comparison of the diagnostic performance of (18)F-FDG PET\/CT and MRI in differentiating benign and malignant ovarian or adnexal tumors: a systematic review and meta-analysis. BMC Cancer. 2021;21(1):1080.","journal-title":"BMC Cancer"},{"issue":"2","key":"2107_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/RLU.0000000000000657","volume":"40","author":"J Ge","year":"2015","unstructured":"Ge J, Zuo C, Guan Y, et al. Increased 18F-FDG uptake of widespread endometriosis mimicking ovarian malignancy. Clin Nucl Med. 2015;40(2):186\u20138.","journal-title":"Clin Nucl Med"},{"issue":"2","key":"2107_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/RLU.0000000000004008","volume":"47","author":"JI Bang","year":"2022","unstructured":"Bang JI, Kim JY, Choi MC, et al. Application of Multimodal Imaging Biomarker in the Differential Diagnosis of Ovarian Mass: Integration of Conventional and Molecular Imaging. Clin Nucl Med. 2022;47(2):117\u201322.","journal-title":"Clin Nucl Med"},{"issue":"8","key":"2107_CR15","doi-asserted-by":"publisher","first-page":"e394","DOI":"10.1097\/RLU.0000000000001234","volume":"41","author":"S Bacanovic","year":"2016","unstructured":"Bacanovic S, Stiller R, Pircher M, et al. Ovarian Hyperstimulation and Oocyte Harvesting Prior to Systemic Chemotherapy-A Possible Pitfall in 18F-FDG PET\/CT Staging of Oncologic Patients. Clin Nucl Med. 2016;41(8):e394\u20136.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"2107_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12149-010-0428-0","volume":"25","author":"R Minamimoto","year":"2011","unstructured":"Minamimoto R, Senda M, Terauchi T, et al. Analysis of various malignant neoplasms detected by FDG-PET cancer screening program: based on a Japanese Nationwide Survey. Ann Nucl Med. 2011;25(1):45\u201354.","journal-title":"Ann Nucl Med"},{"issue":"6","key":"2107_CR17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, et al. (68)Ga-FAPI PET\/CT: Tracer Uptake in 28 Different Kinds of Cancer. J Nucl Med. 2019;60(6):801\u20135.","journal-title":"J Nucl Med"},{"issue":"3","key":"2107_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/RLU.0000000000003488","volume":"46","author":"J Morawitz","year":"2021","unstructured":"Morawitz J, Kirchner J, Martin O, et al. Prospective Correlation of Prognostic Immunohistochemical Markers With SUV and ADC Derived From Dedicated Hybrid Breast 18F-FDG PET\/MRI in Women With Newly Diagnosed Breast Cancer. Clin Nucl Med. 2021;46(3):201\u20135.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"2107_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40644-021-00424-4","volume":"21","author":"HW Kwon","year":"2021","unstructured":"Kwon HW, Lee JH, Pahk K, et al. Clustering subtypes of breast cancer by combining immunohistochemistry profiles and metabolism characteristics measured using FDG PET\/CT. Cancer Imaging. 2021;21(1):55.","journal-title":"Cancer Imaging"},{"issue":"8","key":"2107_CR20","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, et al. Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020;47(8):1820\u201332.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2107_CR21","doi-asserted-by":"publisher","first-page":"9750080","DOI":"10.1155\/2021\/9750080","volume":"2021","author":"C Gundogan","year":"2021","unstructured":"Gundogan C, Guzel Y, Can C, et al. FAPI-04 Uptake in Healthy Tissues of Cancer Patients in (68)Ga-FAPI-04 PET\/CT Imaging. Contrast Media Mol Imaging. 2021;2021:9750080.","journal-title":"Contrast Media Mol Imaging"},{"issue":"4","key":"2107_CR22","doi-asserted-by":"publisher","first-page":"e170490","DOI":"10.1172\/JCI170490","volume":"134","author":"K Li","year":"2024","unstructured":"Li K, Liu W, Yu H, et al. 68Ga-FAPI PET imaging monitors response to combined TGF-betaR inhibition and immunotherapy in metastatic colorectal cancer. J Clin Invest. 2024;134(4):e170490.","journal-title":"J Clin Invest"},{"issue":"10","key":"2107_CR23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41568-024-00740-4","volume":"24","author":"L Arpinati","year":"2024","unstructured":"Arpinati L, Carradori G, Scherz-Shouval R. CAF-induced physical constraints controlling T cell state and localization in solid tumours. Nat Rev Cancer. 2024;24(10):676\u201393.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2107_CR24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1158\/0008-5472.CAN-07-5714","volume":"68","author":"RF Hwang","year":"2008","unstructured":"Hwang RF, Moore T, Arumugam T, et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008;68(3):918\u201326.","journal-title":"Cancer Res"},{"issue":"12","key":"2107_CR25","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1007\/s00259-021-05378-0","volume":"48","author":"K Dendl","year":"2021","unstructured":"Dendl K, Koerber SA, Finck R, et al. (68)Ga-FAPI-PET\/CT in patients with various gynecological malignancies. Eur J Nucl Med Mol Imaging. 2021;48(12):4089\u2013100.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2107_CR26","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCRESAHA.122.320781","volume":"132","author":"Y Sun","year":"2023","unstructured":"Sun Y, Ma M, Cao D, et al. Inhibition of Fap Promotes Cardiac Repair by Stabilizing BNP. Circ Res. 2023;132(5):586\u2013600.","journal-title":"Circ Res"},{"issue":"12","key":"2107_CR27","doi-asserted-by":"publisher","first-page":"4822","DOI":"10.7150\/thno.99046","volume":"14","author":"F Long","year":"2024","unstructured":"Long F, Zhong W, Zhao F, et al. DAB2 (+) macrophages support FAP (+) fibroblasts in shaping tumor barrier and inducing poor clinical outcomes in liver cancer. Theranostics. 2024;14(12):4822\u201343.","journal-title":"Theranostics"},{"issue":"1","key":"2107_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13059-024-03243-5","volume":"25","author":"K Stamatiou","year":"2024","unstructured":"Stamatiou K, Huguet F, Serapinas LV, et al. Ki-67 is necessary during DNA replication for fork protection and genome stability. Genome Biol. 2024;25(1):105.","journal-title":"Genome Biol"},{"issue":"Pt 4","key":"2107_CR29","doi-asserted-by":"publisher","first-page":"141817","DOI":"10.1016\/j.ijbiomac.2025.141817","volume":"306","author":"B Li","year":"2025","unstructured":"Li B, Li H, Cheng X, et al. Long non-coding RNA LINC01232 promotes malignancy of prostate cancer through regulation of miR-181a-5p\/IRS2 pathway: Ki-67 protein molecular structure and function. Int J Biol Macromol. 2025;306(Pt 4):141817.","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"2107_CR30","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41580-025-00842-3","volume":"26","author":"Y Liu","year":"2025","unstructured":"Liu Y, Stockwell BR, Jiang X, et al. p53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases. Nat Rev Mol Cell Biol. 2025;26(8):600\u201314.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2107_CR31","doi-asserted-by":"crossref","unstructured":"Balaceanu LA, Grigore C, Dina I et al. CA125 as a Potential Biomarker in Non-Malignant Serous Effusions: Diagnostic and Prognostic Considerations. J Clin Med. 2025;14(12):4152.","DOI":"10.3390\/jcm14124152"},{"key":"2107_CR32","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.2147\/IJWH.S471058","volume":"16","author":"T Li","year":"2024","unstructured":"Li T, Hou N, Mao L, et al. Tumor Markers in Differential Diagnosis of Benign Ovarian Masses. Int J Womens Health. 2024;16:1517\u201331.","journal-title":"Int J Womens Health"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02107-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02107-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02107-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:49:56Z","timestamp":1781833796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02107-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2107"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02107-9","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Chongqing University Cancer Hospital (CZLS2021027-A), and written informed consent was obtained from all patients. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee, as well as the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}